Radical Prostatectomy and Perioperative Fluid Therapy

/Home/Prostate Cancer Treatment Options/Ongoing Clinical Trials for Prostate Cancer/On Going Clinical Trials for Prostate Cancer Drugs

Radical Prostatectomy and Perioperative Fluid Therapy
Basic Trial Information
Trial Description
Summary
Eligibility Criteria
Trial Contact Information

Basic Trial Information

Phase
Type
Status
Age
Sponsor
Protocol IDs



Phase IV


Supportive care


Active


18 to 80


Other


RCT_PROST_ORTO
NCT00771966


Trial Description


Summary

The optimal amount of fluid a patient need under surgery is not clear. Both to much and to little fluid can damage the organ functions.

A strategy called "Goal directed therapy", where the fluid amount a patient need is guided by the stroke volume, has shown to minimize post-operative nausea and vomiting.

The investigators intend to investigate if patients treated after these standards, has a better outcome then patients treated after normal regimes, regarding post-operative orthostatic-hypotension.

Eligibility Criteria

Inclusion Criteria:

Patients with cancer in there prostate
Exclusion Criteria:

Patients who don't understand the information
ASA > III
Patients that are under treatment with the drug triazolam
Patients with af known renal decease
Patients with a psychiatric decease
Alcohol abuse
Severe haemorrhagic decease
Cancer in the mouth,pharynx, larynx or oesophagus
Trial Contact Information


Trial Lead Organizations/Sponsors

Rigshospitalet - Copenhagen University Hospital

Trial Sites

Denmark

Copenhagen